22 completed. 22 Phase 2, 5 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 22 | Completed 22 |
| Phase 1 | 5 | Completed 5 |
| Phase 3 | 3 | Completed 3 |
Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neurobiology of Bulimia Nervosa Estradiol, Micronized progesterone, Leuprolide Acetate - Bulimia Nervosa | Phase 2 | Completed | University of North Carolina, Chapel Hill | 10 | 2020-02-24 | 2022-07-26 |
| A Behavioral Activation Intervention Administered in a College Freshman Orientation Course behavioral activation - Alcohol; Use, Problem, Stress | Phase 2 | Completed | University of Kansas | 572 | 2019-09-05 | 2026-05-28 |
| Intensive Nutrition in Critically Ill Adults Supplemental parenteral nutrition - Critical Illness, Critically Ill | Phase 2 | Completed | Australian and New Zealand Intensive Care Research Centre | 240 | 2018-10-15 | 2024-05-24 |
| LIPIDS-P Trial Phase I/II Trial Smoflipid - Sepsis, Severe, Septic Shock | Phase 1 / Phase 2 | Completed | University of Florida | 59 | 2018-08-17 | 2025-08-11 |
| Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome Intranasal Oxytocin (IN-OXT), Matched Placebo - Prader-Willi Syndrome, Hyperphagia | Phase 2 | Completed | Eric Hollander | 32 | 2018-04-11 | 2025-02-07 |
| Biology and Experience of Eating in Women With Obesity Naloxone, Placebo - Obesity | Phase 2 | Completed | University of California, San Francisco | 41 | 2017-05-20 | 2021-11-03 |
| Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome Intranasal Oxytocin (IN-OXT), Matched Placebo - Prader-Willi Syndrome, Hyperphagia | Phase 2 | Completed | Montefiore Medical Center | 23 | 2015-10-01 | 2021-10-07 |
| Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome Setmelanotide, Placebo - Prader-Willi Syndrome | Phase 2 | Completed | Rhythm Pharmaceuticals, Inc. | 40 | 2015-03-19 | 2023-07-27 |
| Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis Omegaven™ - Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis | Phase 2 | Completed | University of Nebraska | 72 | 2009-05-01 | 2023-10-05 |
| Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN ClinOleic 20% Intravenous Emulsion, Intralipid, 20% Intravenous Emulsion - Parenteral Nutrition | Phase 2 / Phase 3 | Completed | Emory University | 100 | 2008-11-01 | 2018-10-17 |
| Binge Eating and Chromium Study Sugar Pill, chromium picolinate - Binge Eating Disorder | Phase 1 / Phase 2 | Completed | University of North Carolina, Chapel Hill | 26 | 2008-07-01 | 2012-04-03 |
| Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity Interpersonal Psychotherapy, Health Education - Obesity, Overweight | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 166 | 2008-05-15 | 2019-10-01 |
| Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies omegaven - Colitis, Mucositis | Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 14 | 2007-11-01 | 2015-07-23 |
| Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals Topiramate - Alcohol Dependence, Binge Eating | Phase 2 | Completed | University of Virginia | 5 | 2006-03-01 | 2017-07-12 |
| Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants Lipofundin MCT/LCT 20 %, Lipidem 20% - Preterm Infants, Parenteral Nutrition n-3 Fatty Acids | Phase 2 | Completed | B. Braun Melsungen AG | 48 | 2006-01-01 | 2021-03-10 |
| Craving, Binge Eating and Obesity bupropion, Placebo - Binge Eating Disorder, Obesity | Phase 2 / Phase 3 | Completed | Yale University | 61 | 2005-12-01 | 2020-04-03 |
| Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery a combination of MCT, LCT , and Fish Oil - Inflammation, Cardiac Surgical Procedures | Phase 2 / Phase 3 | Completed | University of Alberta | 32 | 2005-11-01 | 2007-11-27 |
| Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents Cognitive Behavioral Therapy - Bulimia Nervosa | Phase 1 / Phase 2 | Completed | Kaiser Permanente | 26 | 2005-09-01 | 2010-02-15 |
| Parenteral Nutrition Support for Patients With Pancreatic Cancer parenteral nutrition - Cancer Cachexia, Pancreatic Cancer | Phase 2 | Completed | CONKO-Studiengruppe | 32 | 2002-01-01 | 2009-06-12 |
| Family Therapy for Adolescent Bulimia Nervosa FBT-BN, SPT - Bulimia Nervosa | Phase 2 | Completed | University of Chicago | 80 | 2001-04-01 | 2013-09-05 |
Showing 20 of 22. Sign in to see all of them.
Bulimia (11) · Obesity (7) · Binge-Eating Disorder (4) · Bulimia Nervosa (3) · Prader-Willi Syndrome (3) · Alcoholism (2) · Mental Disorders (2) · Cholestasis (1) · Colitis (1) · Critical Illness (1) · Cross Infection (1) · Depression (1) · Emotional Eating (1) · Feeding and Eating Disorders (1)
Pathological Conditions, Signs and Symptoms (22) · Signs and Symptoms (22) · Signs and Symptoms, Digestive (22) · Nutritional and Metabolic Diseases (10) · Nutrition Disorders (9) · Overnutrition (9) · Overweight (8) · Body Weight (7) · Mental Disorders (7) · Feeding and Eating Disorders (6) · Pathologic Processes (4) · Abnormalities, Multiple (3) · Chromosome Disorders (3) · Congenital Abnormalities (3)
Cognitive Behavioral Therapy (3) · Oxytocin (2) · Sugars (2) · fish oil triglycerides (2) · Bupropion (1) · ClinOleic (1) · Estradiol (1) · Fat Emulsions, Intravenous (1) · Fish Oils (1) · Interpersonal Psychotherapy (1) · Leuprolide (1) · Naloxone (1) · Parenteral Nutrition (1) · Parenteral Nutrition, Total (1) · Progesterone (1)
University of North Carolina, Chapel Hill (2) · Washington University School of Medicine (2) · Australian and New Zealand Intensive Care Research Centre (1) · B. Braun Melsungen AG (1) · CONKO-Studiengruppe (1) · Emory University (1) · Eric Hollander (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Insel Gruppe AG, University Hospital Bern (1) · Kaiser Permanente (1) · Montefiore Medical Center (1) · Rhythm Pharmaceuticals, Inc. (1) · University of Alberta (1) · University of California, San Francisco (1) · University of Chicago (1)
United States (16) · Germany (2) · Australia (1) · Canada (1) · New Zealand (1) · Switzerland (1)
Denise E Wilfley, Ph.D. (2) · Eric Hollander, MD (2) · Ashley E Mason, PhD (1) · Berthold V. Koletzko, Prof., MD (1) · Daniel Le Grange, PhD (1) · David F Mercer, MD, PhD (1) · David Meeker (1) · Emma Ridley, PhD (1) · Faheem W Guirgis, MD (1) · Guillermo Umpierrez, MD (1) · Jack A Yanovski, M.D. (1) · Jessica Baker, PhD (1) · John E Van Aerde, MD, PhD (1) · Kimberly A Brownley, PhD (1)
PMID 12150647, PMID 20214798, PMID 22136963, PMID 22282429, PMID 22488002, PMID 23201707, PMID 23656848, PMID 23751236, PMID 23909727, PMID 25240070, PMID 26210388, PMID 27808536, PMID 29607525, PMID 29924393, PMID 31537565, PMID 31982647, PMID 33315720, PMID 33392541, PMID 35260448, PMID 36833579, PMID 37583941, PMID 38488429, PMID 39716214, PMID 39762887
K23DK071646 (1), R01AA027791 (1), R21MH121726 (1)